Saturday Rounds: Week of September 6-11, 2026

Four approvals, a first-ever in-vivo CRISPR filing accepted with Priority Review, two high-profile pivotal misses, and roughly $1.6 billion of confirmed private financing — a week where mechanism mattered less than manufacturing, endpoint choice and data integrity. Weekly Biotech Signal Review · Completed reporting week:…